US Patent Issued to Novartis on April 7 for "Methods of treating inflammatory arthritis using IL-17 antagonists" (Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,333, issued on April 7, was assigned to Novartis AG (Basel, Switzerland).

"Methods of treating inflammatory arthritis using IL-17 antagonists" was invented by Shephard Mpofu (Oberwil, Switzerland), Hanno Richards (Therwil, Switzerland), Karthinathan Thangavelu (Geneva) and Matthias Machacek (Allschwil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to novel regimens for treating an inflammatory arthritis, e.g., psoriatic arthritis, which employ a therapeutically effective amount of an Interleukin-17 (IL-17) antagonist, e.g., IL-17 binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof, e.g., sec...